GGrantIndex
Sort

27,075 grants matching cholesterol

Cell Cycle Control of Restenosis by apoE

$497,630
Richard Assoian · University Of Pennsylvania · P01 · FY2012 · HL

CENTER FOR AMERICAN INDIAN AND ALASKA NATIVE DIABETES TRANSLATION RESEARCH

$497,605
Spero M Manson · University Of Colorado Denver · P30 · FY2020 · DK

ISOPRENOID METABOLISM IN THE RETINA

$497,583
Steven J. Fliesler · State University Of New York At Buffalo · R01 · FY2012 · EY

Extracellular regulation of lipoprotein lipase activity

$497,545
Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2015 · HL

Energetics of Channel-Bilayer Interactions

$497,542
Weill Medical College Of Cornell Univ · R01 · FY2005 · GM

Molecular mechanisms and therapeutic targeting of PI3K-p110beta/PTEN signaling in breast cancer and cancer immunity

$497,522
Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Vulnerability of DHCR7+/- mutation carriers to aripiprazole and trazodone treatment

$497,513
Karoly Mirnics · University Of Nebraska Medical Center · R01 · FY2017 · MH

Aging and Leydig Cell Function

$497,504
Barry R Zirkin · Johns Hopkins University · R01 · FY2017 · AG

Scavenger Receptors: Ligand Binding and Pathophysiology

$497,466
Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2009 · HL

Rest and Exercise Hemodynamics in AAA Progression

$497,419
Charles Anthony Taylor · Stanford University · P50 · FY2010 · HL

TERPENE CONDENSATION REACTIONS

$497,369
University Of Utah · R37 · FY2000 · GM

Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk

$497,332
Joe V Selby · Kaiser Foundation Research Institute · R18 · FY2007 · HS

Lipase Expression and its Role in the Metabolic Syndrome.

$497,316
Howard Wong · University Of California Los Angeles · P01 · FY2007 · HL

Neuroprotection with Statin Therapy for Acute Recovery Trial (NeuSTART)

$497,310
Mitchell S Elkind · Columbia University Health Sciences · P50 · FY2012 · NS

Metal Exposure and Children?s Preschool Neurodevelopment

$497,241
David C Bellinger · Boston Children'S Hospital · R01 · FY2009 · ES

Prevent Unnecessary Carotid Intervention and Stroke using Noninvasive Transcutaneous Ultrasound Thermal Strain Imaging (US-TSI)

$497,210
Kang Kim · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL

The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

$497,164
Andrew W Gardner · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · AG

Scavenger Receptors: Ligand Binding and Pathophysiology

$497,122
Monty Krieger · Massachusetts Institute Of Technology · R01 · FY2011 · HL

THE CLINICAL EFFECTIVENESS OF PHARMACY ADHERENCE INFORMATION FOR DIABETES CONTROL

$497,120
Manel Pladevall · Henry Ford Health System · R01 · FY2007 · DK

CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS

$497,111
Ninh La-Beck · Texas Tech University Health Scis Center · R01 · FY2023 · CA

Endothelial-Interstitial Interactions in Aortic Valve Homeostasis and Disease

$497,109
Jonathan Talbot Butcher · Cornell University · R01 · FY2020 · HL

Comparative Effectiveness of Adding Family Supporter Training and Engagement to a CHW-Led Intervention to Improve Behavioral Management of Multiple Risk Factors for Diabetes Complications

$497,103
Ann-Marie Rosland · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK

Cholesterol metabolism in mesenchymal colorectal cancer

$496,987
Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes

$496,938
Marian J. Rewers · University Of Colorado Denver · RC1 · FY2010 · DK

GGT Targeting Suppresses Mast Cell Activation by IgE and IL-33

$496,732
John J Ryan · Virginia Commonwealth University · R01 · FY2019 · AI